🚀Event Sharing: 2024 MOHW Cancer Research Annual Meeting & International Symposium 🚀 The upcoming 2024 Annual Meeting of MOHW Cancer Research Projects and International Symposium will be Dec. 07. This year's theme is "New Frontier Technology in Cancer Care", focusing on innovative advancements in the fight against cancer. This event will bring together international experts, researchers, and professionals to explore cutting-edge technologies shaping the future of cancer care. From AI-driven treatments to breakthroughs in diagnostics, this is a fantastic opportunity to network, learn, and collaborate on the next generation of cancer solutions. Don’t miss out on this chance to gain insights and make valuable connections in the oncology field. More details and registration can be found here: Event Link. #CancerResearch #Oncology #HealthTech #Innovation #NHRI #CancerCare #MedicalTechnology
TiBIA (Taiwan Biomedical Innovation Association)’s Post
More Relevant Posts
-
The newly released American Association for Cancer Research (AACR) Cancer Progress Report 2024 offers a comprehensive overview of the latest advancements in cancer research, treatment, and survivorship. It highlights the important role that ongoing scientific efforts play in improving patient outcomes and reducing cancer mortality. This report reminds us that robust investment in basic, translational, and clinical research is essential for driving innovation in the fight against cancer. Imagene is committed to developing solutions that support innovation and rapid discoveries, enabling researchers and developers to leverage Oncology Intelligence without the need for AI expertise or extensive data - barriers that can often slow down breakthroughs in cancer research. https://lnkd.in/eAhPWi-w #OncologyIntelligence #CancerProgress #AACR #CancerResearch
-
The 2024 National Foundation for Cancer Research (NFCR) Global Summit: Advancements and Collaboration in Cancer Research 🌍🧬 The National Foundation for Cancer Research (NFCR) is hosting the 2024 Global Summit and Award Ceremonies, a pivotal event for leaders in cancer research and oncology. This summit will feature presentations, panel discussions, and networking opportunities, focusing on the latest advancements and future directions in cancer research. 🔬 The event brings together top scientists, researchers, and cancer advocates to discuss and celebrate recent breakthroughs and explore new strategies for combating cancer. Attendees will gain valuable insights and actionable strategies to advance their work, with a focus on practical solutions and collaborative efforts. 🤝💡 Dennis Slamon Margaret Foti Drew Pardoll Siddhartha Mukherjee https://lnkd.in/exeUNER8 For those dedicated to advancing cancer research and improving patient outcomes, the 2024 NFCR Global Summit offers a unique opportunity to engage with the forefront of innovation in the field. 🚀🔍 #NFCRGlobalSummit #CancerResearch #Cancer #Oncology #OncoDaily
-
-
🌟Theme: Redefining Cancer Research Horizons 🌟 Get ready for an exciting journey into the future of cancer care at the Cancer Care Conference - Global Edition in Boston, USA, on March 27-28, 2025! This year, we are Redefining Cancer Research Horizons! Don’t miss the opportunity to engage with trailblazing experts, discover groundbreaking research, and be part of transforming the landscape of cancer care. Join us to challenge the limits, explore new frontiers, and collaborate with like-minded professionals. This is your chance to be at the heart of the revolution in oncology! 🎯 Let’s redefine what’s possible in cancer care and make a global impact together! . . #PushingBoundaries #CancerResearch #OncologyInnovation #GlobalImpact #CancerCare #FutureOfCancerTreatment #CancerResearchConference #OncologyExperts #MedicalInnovation #BreakthroughResearch #FightAgainstCancer #CollaborateForChange #RedefiningCancerCare #AdvancementsInOncology #GlobalMedicalCommunity
-
-
TRIO has set the standard in cancer clinical trials execution. If you are a cancer clinical investigator, we invite you to join our global network of investigators and elevate oncology research together. You will get: · Access to TRIO trials: Receive early invitations to join new trials, ongoing updates about our cutting-edge research and invitations to specialized events · Global collaboration: Connect with peers conducting TRIO trials worldwide and have the opportunity to contribute to trials design. · Recognition and growth: Be recognized for your contributions. · Lead alongside Dr. Dennis Slamon, a pioneer in cancer treatment, and impact patient outcomes through groundbreaking trials. 🌐 Discover how your expertise can transform cancer care with TRIO. Let’s redefine the future of oncology together: https://lnkd.in/ge3WCF2P #OncologyInnovation
-
-
Just sharing for those in my network. Our regulatory and clinical experts are ready for a conversation with you at AACR! Please contact me or stop by our exhibit booth 3557 to discuss how TD2 can advance your cancer therapy!
Save the Date for #AACR2024! We're thrilled to announce that TD2 will be attending the upcoming AACR Conference in sunny San Diego! It's an incredible opportunity to connect with fellow researchers, innovators, and thought leaders in the field of cancer research. Schedule a meeting here: https://hubs.li/Q02pnD3p0 📍 Visit Us at Booth 3557: Come meet our dedicated team to learn more about how we're advancing research for new cancer therapies. Whether you're interested in the latest in oncology research or seeking partnerships, we're excited to share our insights and collaborate on future projects. 🔬 Don’t Miss Our Poster Presentations: TD2 is proud to present 3 groundbreaking posters during the conference. These presentations will showcase our latest research findings and innovative approaches to tackling complex challenges in cancer research. Stay tuned for the presentation schedule and topics – we promise it's something you won't want to miss! We look forward to seeing you there and engaging in meaningful discussions. Together, we can make a difference in the lives of those affected by cancer. See you at Booth 3557! #AACR #CancerResearch #Oncologyresearch #TD2
-
-
Executive Vice President at Thermo Fisher Scientific. Leads technology businesses. Passionate about excellence and digital innovation in life science and diagnostics. Precision Medicine
Today we are taking a major step forward in advancing #precisionmedicine for cancer patients. Because when you’re facing a cancer diagnosis, every minute matters. In partnership with the National Cancer Institute (NCI) our team Thermo Fisher Scientific is providing groundbreaking #genomic testing for myeloMATCH clinical trials. Using our Genexus System, clinical teams can now quickly match eligible cancer patients with the right trials based on their genomic profile. Delivering next-day results, our system can quickly bring new targeted therapies to patients and accelerate our understanding of genomic factors in treating myeloid cancers. #oncology #precisionmedicine #innovation #technology Check this out: https://lnkd.in/dDyuFxmk
-
The Oncology Institute "Prof. Dr. Ion Chiricuță" Cluj-Napoca (IOCN) hosts partners of the ECHoS (Establishing of Cancer Mission Hubs: Networks and Synergies) project and European Commission representatives. ECHoS | Establishing of Cancer Mission Hubs: Networks and Synergies, funded by Horizon Europe, aims to support Cancer Mission activities across Europe by creating and developing National Cancer Mission Hubs at various levels. The event focuses on enhancing cancer prevention and control efforts through collaborative networks and synergies across Europe. 📍 Institutul Oncologic „Prof. Dr. Ion Chiricuță” Cluj-Napoca #oncology #cancermission #cancerprevention #networks #europe
-
-
🌐 Advancing Cancer Diagnostics with MP-SPR! 🌐 Discover how BioNavis Oy is setting new standards in cancer diagnostics. Their latest research explores the potent capabilities of MP-SPR in the early detection of ovarian cancer through non-invasive methods. 🔎 Key Outcomes: Real-Time Analysis: MP-SPR offers a label-free, highly sensitive approach to measure the interactions of extracellular vesicles and specific proteins, providing immediate insights into cellular communication and disease markers. Precision in Cancer Research: The study highlighted MP-SPR's effectiveness in identifying specific tumor markers (α3β1 integrin), offering a promising avenue for early cancer detection and potential therapeutic interventions. Leverage MP-SPR for cutting-edge diagnostics and enhance your research capabilities in the fight against cancer. #CancerResearch #Diagnostics #MPSPR #LifeSciences #Innovation
-
#ILLINOIS researcher Tim Fan is expanding his work in immunotherapy with a new project aimed at improving the immune system's ability to fight cancer. 🔶 His most recent project is supported by a BEAT Cancer Research Initiative Grant. The Breakthrough Engineering and Advanced Treatment (BEAT) of Cancer Research Initiative is a collaboration between the CCIL and the OSF HealthCare Cancer Institute, creating an opportunity for researchers and clinicians to develop innovative cancer treatment and care solutions. 👉 https://lnkd.in/gdsTCiUD
-
-
Today, September 24, is World Cancer Research Day. World Cancer Research Day aims to highlight the shared goals of improving the quality of life and survival for people with cancer, reducing the global impact of cancer, increasing access to research results, reducing disparities in cancer outcomes, and the importance of innovation in all aspects of cancer research, from prevention to treatment. At WCG, we are proud to partner with, and lead the charge alongside, the heroes who help make innovation and breakthroughs in cancer research possible. Discover how WCG is optimizing the modern Oncology clinical trial process at https://lnkd.in/eEZcmUuh #WCRD #WorldCancerResearchDay #WCG #cancerresearch #clinicaltrial #clinicalresearch
-
